NASDAQ:ABUS - Arbutus Biopharma Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $11.55 +0.15 (+1.32 %) (As of 07/20/2018 02:13 PM ET)Previous Close$11.50Today's Range$11.45 - $11.9552-Week Range$3.20 - $12.05Volume15,406 shsAverage Volume833,219 shsMarket Capitalization$623.40 millionP/E Ratio-6.37Dividend YieldN/ABeta0.99 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Arbutus Biopharma (NASDAQ:ABUS) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.5 Wall Street analysts have issued ratings and price targets for Arbutus Biopharma in the last 12 months. Their average twelve-month price target is $8.80, suggesting that the stock has a possible downside of 23.81%. The high price target for ABUS is $13.00 and the low price target for ABUS is $5.00. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldBuyBuyBuyConsensus Rating Score: 2.402.602.672.83Ratings Breakdown: 0 Sell Rating(s)3 Hold Rating(s)2 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)1 Hold Rating(s)5 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $8.80$8.40$12.3750$12.50Price Target Upside: 23.81% downside39.53% upside135.71% upside140.38% upsideArbutus Biopharma (NASDAQ:ABUS) Consensus Price Target History Arbutus Biopharma (NASDAQ:ABUS) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails7/16/2018Chardan CapitalReiterated RatingBuy$11.00High7/6/2018B. RileyDowngradeBuy ➝ Neutral$9.00 ➝ $9.00High3/19/2018WedbushDowngradeOutperform ➝ Neutral$9.00 ➝ $6.00Medium11/7/2017Leerink SwannReiterated RatingMarket Perform$4.00 ➝ $5.00N/A10/4/2017JMP SecuritiesReiterated RatingOutperform$12.00 ➝ $13.00High6/2/2017LADENBURG THALM/SH SHInitiated CoverageBuy$32.00Low1/9/2017Bloom BurtonUpgradeAccumulate ➝ BuyN/A8/21/2016William BlairReiterated RatingOutperformN/A(Data available from 7/20/2016 forward) This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?